American Society of Echocardiography (ASE)

The American Society of Echocardiography (ASE) is the key cardiovascular ultrasound medical society. ASE works to advance cardiac ultrasound, offers clinical education, research, government policy advocacy, and services to the professionals and the public.

Thumbnail

Pocket-sized: Pointers for Using (& Not Using) Handheld Point-of-Care Echocardiography

Handheld POC echo has proven useful in- and outside of the emergency department, but physicians still have reservations.

Thumbnail

Philips updates, expands cardiac ultrasound platform

Royal Philips has rolled out the latest update for its EPIQ CVx and EPIQ CVxi cardiac ultrasound systems, expanding to include automated applications for 2D assessment of the heart and robust 3D measurements of right ventricular volume and ejection fraction.

Ultrasound societies want the FDA to remove contrast label warning

The International Contrast Ultrasound Society (ICUS) is again urging the FDA to remove the “black box” warning from ultrasound contrast agent (UCA) labels, following its filing of a September 2018 citizen petition with the federal agency.

Thumbnail

American Society of Echocardiography unveils new guidelines for comprehensive TTE

The American Society of Echocardiography has released new guidelines for performing a comprehensive transthoracic echocardiography (TTE) examination. The recommendations, which were endorsed by 22 other cardiology/echocardiography societies from around the world, were published in the January edition of the Journal of the American Society of Echocardiography.

Thumbnail

Jonathan R. Lindner elected president of American Society of Echocardiography

Jonathan R. Lindner, MD, was elected president of the American Society of Echocardiography (ASE) at the ASE’s 29th Annual Scientific Sessions in Nashville, Tennessee.

Thumbnail

Jonathan Lindner elected president of the American Society of Echocardiography

The 17,000-member American Society of Echocardiography (ASE) named Jonathan R. Lindner, MD, president of the organization during its 29th annual scientific sessions in Nashville, Tennessee.

Thumbnail

FDA-approved AI echocardiogram software bests cardiologists in reducing LVEF variability

A deep-learning software that can automatically calculate left ventricular ejection fraction (LVEF) with less variability than a cardiologist recently received approval from the U.S. Food and Drug Administration (FDA).

Thumbnail

AI-assisted echocardiogram analysis improves reproducibility of LVEF measurements

A deep-learning algorithm can automatically calculate left ventricular ejection fraction (LVEF) with less variability than cardiologists, according to a study presented June 25 at the American Society of Echocardiography’s annual scientific sessions.